Skip to content
Sign in
Artwork for David's Gemini Notebook Podcast Collection
David's Gemini Notebook Podcast Collection · September 25 · 49 min

David Sinclair and the Quest to Reverse Aging

What if aging cells could recover the instructions that once kept them young? This episode explores David Sinclair’s information theory of aging and the science of partial epigenetic reprogramming—an effort to restore youthful cell function without erasing what makes each cell itself. From experiments in mouse eyes to an early human trial targeting optic nerve disease, we unpack the biological “software” metaphor, the Yamanaka factors, and why the eye has become a testing ground for this ambitious research. Then we examine the distance between a laboratory breakthrough and a treatment you can safely use. We explore the obstacles to whole-body rejuvenation, controversies surrounding resveratrol and NAD+ supplements, and why a younger-looking biomarker doesn’t automatically mean better health. The conversation closes with exercise, sleep, nutrition, and a practical framework for evaluating longevity claims. How can we recognize meaningful progress when the promise of turning back time is also such a powerful sales pitch?

0:00-49:16
Play in

transcript

No transcript — this publisher did not publish one.

show notes

What if aging cells could recover the instructions that once kept them young? This episode explores David Sinclair’s information theory of aging and the science of partial epigenetic reprogramming—an effort to restore youthful cell function without erasing what makes each cell itself. From experiments in mouse eyes to an early human trial targeting optic nerve disease, we unpack the biological “software” metaphor, the Yamanaka factors, and why the eye has become a testing ground for this ambitious research.

Then we examine the distance between a laboratory breakthrough and a treatment you can safely use. We explore the obstacles to whole-body rejuvenation, controversies surrounding resveratrol and NAD+ supplements, and why a younger-looking biomarker doesn’t automatically mean better health. The conversation closes with exercise, sleep, nutrition, and a practical framework for evaluating longevity claims. How can we recognize meaningful progress when the promise of turning back time is also such a powerful sales pitch?

more episodes

All episodes